Marquette Asset Management, LLC Infla Rx N.V. Transaction History

Marquette Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 12, 2023	SELL	$2.11 - $3.25 $63,202 - $97,350	-29,954 Reduced 50.63%	29,206 $0
Q3 2022 Oct 06, 2022	SELL	$1.32 - $3.14 $25,687 - $61,104	-19,460 Reduced 24.75%	59,160 $0
Q2 2022 Jul 15, 2022	BUY	$0.78 - $1.9 $35,415 - $86,269	45,405 Added 136.7%	78,620 $114,000
Q2 2021 Jul 19, 2021	BUY	$2.72 - $4.04 $90,344 - $134,188	33,215 New	33,215 $99,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Marquette Asset Management, LLC with notifications on news.